Clinical Experience With Regenerative Therapy in Heart Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Experience With Regenerative Therapy in Heart Failure

Published:2018-05-11 Issue:10 Volume:122 Page:1344-1346
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circ Res

Author:

Bartunek Jozef¹,Terzic Andre²,Behfar Atta²,Wijns William³

Affiliation:

1. From the Cardiovascular Center, OLV Hospital, Aalst, Belgium (J.B.)

2. Department of Cardiovascular Medicine and Center for Regenerative Medicine, Rochester, MN (A.T., A.B.)

3. Lambe Institute for Translational Medicine, Curam, National University of Ireland Galway, Saolta University Healthcare Group (W.W.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference15 articles.

1. Clinical development plan for regenerative therapy in heart failure

2. Global position paper on cardiovascular regenerative medicine

3. Stem cell therapy for heart failure: Ensuring regenerative proficiency

4. Cardiopoietic index predicts heart repair fitness of patient-derived stem cells

5. Guided Cardiopoiesis Enhances Therapeutic Benefit of Bone Marrow Human Mesenchymal Stem Cells in Chronic Myocardial Infarction

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoded cardiopoietic cell secretome linkage to heart repair biosignature;Stem Cells Translational Medicine;2024-09-11

2. A Whole‐Course‐Repair System Based on Stimulus‐Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration;Small Methods;2024-06-25

3. An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction;Journal of Controlled Release;2024-01

4. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial;Stem Cells Translational Medicine;2023-11-24

5. Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure;Texas Heart Institute Journal;2023-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3